This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its chiral nature makes it valuable in the development of enantiomerically pure drugs, particularly those targeting central nervous system disorders. It is often employed in the production of fluorinated compounds, which are known for their enhanced bioavailability and metabolic stability. Additionally, its structural features make it suitable for use in organic synthesis and medicinal chemistry research, where it serves as a building block for designing novel therapeutic agents.